The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Pediatric Tuberculosis: Global Overview and Challenges
Abstract
Tuberculosis (TB) is among the top 10 causes of death among children worldwide; however, children with TB are given low priority in most national health programs and are neglected in this epidemic. Recent technological advancements in diagnosis of TB in adults have not been validated in children. Similarly, trials of new drugs and development of pediatric formulations of standard first- and second-line drugs are lagging behind. Among human immunodeficiency virus (HIV)-coinfected children, the optimal timing for highly active antiretroviral therapy initiation and drug combinations that have minimal interactions with anti-TB drugs need further study. Although bacille Calmette-Guérin vaccine, the only vaccine available for TB, protects against disseminated and severe forms of the disease in young children, its safety in the HIV-infected population has been questioned. Multicentric trials are urgently required to help develop improved diagnostic strategies and formulate shorter, more effective, safe, and evidence-based regimens for treatment and prevention of drug-susceptible and drug-resistant TB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trunz, B. B., Fine, P., & Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68507-3 · Cited by 1,114
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Marais, B. J., Gie, R. P., Schaaf, H. S., Hesseling, A. C., Obihara, C. C., Starke, J., Enarson, D. A., Donald, P. R., & Beyers, N. (2004) · PubMed · Cited by 806
Controlled chemoprophylaxis trials in tuberculosis. A general review.
Sh, F. (1970) · PubMed · Cited by 721
(2004) · PubMed · Cited by 463
Liebeschuetz, S., Bamber, S., Ewer, K., Deeks, J., Pathan, A. A., & Lalvani, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17592-2 · Cited by 367
Childhood Pulmonary Tuberculosis: Old Wisdom and New Challenges
Marais, B. J., Gie, R. P., Schaaf, H. S., Beyers, N., Donald, P. R., & Starke, J. R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1809so · Cited by 342
Graham, S. M. (2007) · Europe PMC (PubMed Central) · Cited by 328
Detjen, A. K., Keil, T., Roll, S., Hauer, B., Mauch, H., Wahn, U., & Magdorf, K. (2007) · Clinical Infectious Diseases · doi:10.1086/519266 · Cited by 288
Spyridis, N. P., Spyridis, P. G., Gelesme, A., Sypsa, V., Valianatou, M., Metsou, F., Gourgiotis, D., & Tsolia, M. N. (2007) · Clinical Infectious Diseases · doi:10.1086/520983 · Cited by 259
Cited by
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
Self-citationKetema, L., Dememew, Z. G., Assefa, D., Gudina, T., Kassa, A., Letta, T., Ayele, B., Tadesse, Y., Tegegn, B., Datiko, D. G., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241977 · Cited by 13
Metadata
- Authors
- Swaminathan, S., & Rekha, B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-15
- Volume
- 50
- Issue
- s3
- Pages
- S184-S194
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157972110
- Cited by
- 377
- References
- 37
- FWCI
- 13.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pediatric Tuberculosis: Global Overview and Challenges. https://app.cochat.ai/papers/10.1086/651490
- The paper
- Swaminathan, S., & Rekha, B. (2010). Pediatric Tuberculosis: Global Overview and Challenges. Clinical Infectious Diseases. https://doi.org/10.1086/651490
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
